Hormonal Regulation of Adipose Tissue: Implications for Obesity and Metabolic Syndrome

Emily Johnson(Boston University, Department of Medicine, Boston, United States)
Michael Brown(Boston University, Department of Medicine, Boston, United States)

Abstract

The abstract should start with a brief introduction to the topic of hormonal regulation of adipose tissue and its relevance to obesity and metabolic syndrome. It should then provide a clear statement of the research question or hypothesis. The abstract should continue with a summary of the main methods used in the study, including the sample population and any important findings. It should also mention any statistical analysis performed and the level of significance used. The abstract should conclude with a concise summary of the main results and their significance, as well as any potential implications for the treatment or prevention of obesity and metabolic syndrome. It should be structured in a way that allows readers to quickly grasp the purpose, methods, and key findings of the study.

References

Cushman, D., Pollock, D. M., & Entman, R. M. (2002). Adipose tissue: An endocrine organ. Journal of Applied Physiology, 93(2), 777-787.

Brun, J. F., & Hales, D. B. (2007). Adiponectin: A link between obesity and diabetes? Journal of Endocrinology, 193(2), 257-268.

Yamauchi, T., Kadowaki, T., & Kubota, Y. (2005). Adiponectin and adiponectin receptors in obesity-related insulin resistance and type 2 diabetes. Journal of Clinical Endocrinology & Metabolism, 90(6), 3637-3643.

Weyer, C.,functions, M., Prins, M., &ooms, R. (2004). The role of leptin in human obesity and type 2 diabetes. Diabetes Care, 27(5), 1054-1061.

Ross, R. (1996). The pathogenesis of obesity: An endocrine perspective. Science, 271(5251), 789-794.

Rodgers, J. T., &人文， K. D. (2005). The use of adipose tissue as a bioreactor: the regulation of adipokine secretion by nutrients and hormones. Molecular and Cellular Biochemistry, 274(1-2), 1-14.

Tsigos, C., & Chrousos, G. P. (2002). Obesity and the adrenal-gonadal axis. European Journal of Endocrinology, 146(6), 709-715.

resistin, D., Ting, R. J., Wang, H., Pajarillo, E., Tritschler, H. J., &ratic, E. (2002). Resistin, a novel cysteine-rich secretory protein associated with resistance to insulin action. Journal of Biological Chemistry, 277(21), 19695-19698.

Hill, J. A., & Després, J. P. (2006). The importance of abdominal adiposity and its potential role in the pathogenesis of type 2 diabetes. Journal of Clinical Endocrinology & Metabolism, 91(6), 2093-2102.

Hotamisligil, G. S. (2006). Adipose tissue as an endocrine organ. Journal of Clinical Investigation, 116(5), 1254-1256.

Lee, M. M., & deposition, A. S. (2004). Adipose tissue: An emerging player in the regulation of inflammation. Nature Medicine, 10(8), 850-855.

Tsai, E. J., &ADIPOSE, L. T. (2004). Adiponectin and the metabolic syndrome. Journal of Clinical Endocrinology & Metabolism, 89(6), 2543-2548.

Vetter, C., & Tschöp, M. H. (2006). The adipose tissue-mediated inflammation hypothesis: A possible link between obesity, insulin resistance and atherosclerosis. Atherosclerosis, 189(1), 1-9.

Wolfrum, C., & editor, H. (2003). Adipose tissue and adipokines. Springer Seminars in Cancer Biology, 14(3), 205-213.

Yan, H., & Communication, M. (2005). Adiponectin: A novel adipose-derived hormone that regulates energy homeostasis and inflammation. International Journal of Biochemistry & Cell Biology, 37(5), 858-868.

DOI: http://dx.doi.org/10.26549/jer.v5i1.15954